The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Over The 2026–2030 Period?
The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market has seen rapid expansion in recent years. It is anticipated to grow from $0.68 billion in 2025 to $0.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.3%. The market’s historical development can be ascribed to the increasing prevalence of sexually transmitted infections, the limitations inherent in traditional diagnostic methods, a growing awareness of women’s reproductive health, the expansion of clinical diagnostic laboratories, and the adoption of standard pcr testing protocols.
The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $1.08 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.5%. Several factors contribute to this growth during the forecast period, including an escalating demand for point-of-care molecular diagnostics, progress in multiplex and real-time pcr technology, a rise in the use of home-based testing options, increased spending on molecular diagnostic infrastructure, and the expansion of screening initiatives for sti and vaginitis. Significant trends emerging in the forecast period encompass the increasing acceptance of multiplex pcr panels for detecting sti and vaginitis, a heightened preference for molecular diagnostics that offer speed and high sensitivity, an expanding requirement for pcr testing kits usable at home and collected by individuals, the broader integration of pcr testing into routine women’s health screenings, and a stronger emphasis on identifying pathogens both early and precisely.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27412&type=smp
What Underlying Factors Are Accelerating The Growth Of The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market?
The increasing number of sexual health screenings is projected to fuel the expansion of the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market moving forward. Sexual health screenings encompass medical examinations carried out to identify sexually transmitted infections (STIs) and other associated conditions, ensuring early diagnosis, intervention, and prevention of disease transmission. The rise in these screenings is attributed to the escalating worldwide prevalence of sexually transmitted infections, which has intensified the demand for early detection and prompt treatment to avert complications and reduce infection spread. Sexual health screenings are essential for STI and vaginitis PCR testing, as they facilitate the early and accurate identification of various infections, frequently even when symptoms are absent, thereby supporting immediate treatment and aiding in the prevention of complications and the dissemination of infections. For example, in July 2025, the Bristol City Council, a UK-based government agency, reported that in 2024, sexual health services administered 25,410 STI tests (excluding chlamydia screening for people under 25), which corresponds to 5,260.9 tests per 100,000 population. This rate exceeded the England average of 4,088.8 per 100,000. Consequently, the increasing sexual health screenings are driving the growth of the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market.
How Is The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Segmented Across Key Categories?
The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market covered in this report is segmented –
1) By Test Type: Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels, Vaginitis Polymerase Chain Reaction (PCR) Panels
2) By Condition: Sexually Transmitted Infections, Vaginal Infections
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Or At-Home Testing, Other End Users
Subsegments:
1) By Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels: Chlamydia Trachomatis Polymerase Chain Reaction, Neisseria Gonorrhoeae Polymerase Chain Reaction, Trichomonas Vaginalis Polymerase Chain Reaction, Herpes Simplex Virus Polymerase Chain Reaction, Human Papillomavirus Polymerase Chain Reaction, Mycoplasma Genitalium Polymerase Chain Reaction, Syphilis Polymerase Chain Reaction, Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
2) By Vaginitis Polymerase Chain Reaction (PCR) Panels: Bacterial Vaginosis Polymerase Chain Reaction, Candida Species Polymerase Chain Reaction, Trichomoniasis Polymerase Chain Reaction, Mixed Vaginitis Polymerase Chain Reaction Panels, Aerobic Vaginitis Polymerase Chain Reaction, Atrophic Vaginitis Polymerase Chain Reaction
Which Upcoming Trends Are Expected To Influence The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market?
Leading firms within the sexually transmitted infection (STI) and vaginitis PCR testing market are developing advanced technologies, including multiplex real-time PCR assays, to meet the increasing demand for swift, precise, and thorough identification of pathogens. This multiplex PCR technology facilitates the concurrent amplification and identification of DNA or RNA from numerous pathogens within one test, thereby decreasing both the processing duration and expenditure when contrasted with conventional single-pathogen tests. Furthermore, this method enhances both sensitivity and specificity, making it possible to detect even minute quantities of pathogen genetic material, even during co-infections, which might be overlooked or less dependably identified by standard culture or microscopy techniques. As an illustration, in February 2023, Thermo Fisher Scientific, a US-based biotechnology firm, introduced the Applied Biosystems TrueMark STI Select Panel. This specific multiplex real-time PCR assay was created to identify simultaneously four prevalent STIs: Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium. Primarily for research purposes, this diagnostic tool improves patient care by delivering quicker, exceptionally sensitive results and simplifying laboratory operations, marking a notable progression in molecular STI diagnostic methods.
Who Are The Dominant Players Shaping The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Landscape?
Major companies operating in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Hologic Inc., QIAGEN N.V., ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC S.L., ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd., Sinochips Diagnostics Co Ltd., Vitassay S.L., Bioperfectus Technologies Co. Ltd.
Read the full sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market report here:
Which Region Is Projected To Dominate The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market During The Forecast Period?
North America was the largest region in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in 2025. The regions covered in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27412&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market 2026, By The Business Research Company
Motor Insurance Market Report 2026
https://www.thebusinessresearchcompany.com/report/motor-insurance-global-market-report
Car Insurance Aggregators Market Report 2026
https://www.thebusinessresearchcompany.com/report/car-insurance-aggregators-global-market-report
Automotive Usage Based Insurance Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model